Biotech · Private company · Pottstown, PA, US
Abzyme Therapeutics, LLC
Track this companyFree. Adds Abzyme Therapeutics, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Multi-specific long-acting antibodies for the treatment of retinal neovascular diseasesFiscal year 2025 · $826.1KNIH RePORTER 5R44EY030821-03 · fetched Nov 12, 2026
- Multi-specific long-acting antibodies for the treatment of retinal neovascular diseasesFiscal year 2024 · $831.9KNIH RePORTER 2R44EY030821-02 · fetched Nov 12, 2026